| The pH Sciences Team |
 |
pH Sciences, Inc. was founded by a small group of individuals who wanted
to spread the word about the negative effects of destructive acid in the
body and to develop affordable and safe ways to reduce acid for optimal
health.
Macit Gurol, the founder of a Seattle-based product research
and development company, invented and patented the pH Sciences Alka-Plex
formula that is used in many pH Sciences products. This complex has the
ability to
deliver an alkaline level of 10.6 pH safely into the body. The original
reason for developing this formula arose when Mr. Gurol experienced a
severe case
of heartburn from drinking French roast coffee. After concluding that
the heartburn was caused by the high acid content of the coffee, Mr.
Gurol invented a food
additive to control acid in foods and beverages. It wasn't until other
people tried the product and told him of additional health benefits they
experienced while using his food additive that he realized the magnitude
of what
he had
invented.
Mr. Gurol and his team found that Alka-Plex was effective in promoting
health in areas of the body outside the traditional acidic environment of the
stomach. Continuing years of research has revealed various delivery mechanisms
that provide optimal effectiveness to reduce acid in different parts of the
body. After continued testing and research we reached a point where we felt
compelled to share our discoveries with the world.
The founders remain deeply committed to the Company and are pleased that
the following professionals are leading the Company.
Steve Loyd, Chairman/CEO – Co-founder and Managing Partner of Wax, Loyd & Company,
a boutique investment bank, assisting with mergers, acquisitions and mentoring
high growth companies. Served as temporary CEO for VIP Technologies, a software
company, which he sold to SRS Labs, a public company. Co-founded and served
as general manager of Harbor Development Company for ten years where he oversaw
and managed a successful urban redevelopment group which renovated eleven city
blocks in downtown Seattle with hotels, residential towers, office buildings
and retail establishments. Mr. Loyd was a board member and chief strategist
for Thomas Kemper microbrewery which he sold to a public company. He also helped
start the Program in Entrepreneurship at the University of Washington and served
as a professor for advanced entrepreneurial finance courses in the School of
Business.
Daniel Lanahan, Board Member – Co-founder and Chairman of Lanahan & Reilley
LLP, a 70-attorney law firm headquartered in Santa Rosa, California with offices
in San Francisco, Silicon Valley and Sacramento. Mr. Lanahan has mentored several
start-up companies in the high-tech and bio-tech fields and serves as Chairman
of Endomatrix, a company that has developed a patented composition used to
promote cardiovascular health. He also acted as National Coordinating Counsel
in the nationwide litigation involving the food supplement L-Tryptophan. His
negotiations resulted in a settlement in excess of $3 billion. He is also a
first round investor in TriVascular (abdominal stents), Precision Vascular
(micro devices for minimally invasive surgery), and Acuity (breast cancer scope).
Mr. Lanahan is a founder of the North Bay Angels
John Baillie, Board Member – Co-founder of Quintech Pharmaceuticals,
a company with flash melting drug delivery technology which he sold. Mr. Baillie
served as former director of Apollo Biopharmaceuticals, a company with neurological
products which he merged with a pharmaceutical company. He is a scientist with
expertise in drug development and non-clinical toxicology, an entrepreneur
and a former executive with Quintiles Transnational Corporation.
|
|
